Compare BSTZ & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSTZ | RXRX |
|---|---|---|
| Founded | 2019 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | N/A | 2021 |
| Metric | BSTZ | RXRX |
|---|---|---|
| Price | $26.96 | $4.01 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $7.32 |
| AVG Volume (30 Days) | 162.3K | ★ 27.0M |
| Earning Date | 01-01-0001 | 11-02-2026 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $26.91 |
| P/E Ratio | $39.69 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $20.69 | $2.77 |
| 52 Week High | $31.89 | $5.76 |
| Indicator | BSTZ | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.65 | 51.04 |
| Support Level | $26.56 | $2.90 |
| Resistance Level | $29.63 | $4.09 |
| Average True Range (ATR) | 0.74 | 0.36 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 12.22 | 45.58 |
BlackRock Science and Technology Trust II is a diversified, closed-end management investment company. Its investment objectives are to provide total return and income mainly through long-term capital appreciation. The Trust invests a majority of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range, selected for their rapid and sustainable growth potential from the development, advancement, and use of science and/or technology. Its investment portfolio comprises securities of companies from various industries, such as semiconductors and semiconductor equipment, software, communications equipment, IT services, and entertainment, etc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.